Back
Keros Therapeutics Stock Price Chart
Sponsored
KROS
Sponsored
Supercharge Your Portfolio with This High-Traction AI Startup
Learn More
Buy
62
KROS
Keros Therapeutics
Last Price:
56.44
Seasonality Move:
54.08%
7 Day Trial
ALL ACCESS PASS
$
7
Wall St Issues Rare "SELL" alert
MarketBeat is making the full list completely FREE for a limited time.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KROS is experiencing selling pressure, which indicates risk of future bearish movement.
Keros Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 55.92 | Buy |
20-day SMA: | 53.86 | Buy |
50-day SMA: | 50.03 | Buy |
200-day SMA: | 52.7 | Buy |
8-day EMA: | 55.87 | Buy |
20-day EMA: | 53.93 | Buy |
50-day EMA: | 51.33 | Buy |
200-day EMA: | 49.85 | Buy |
Keros Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.17 | Buy |
Relative Strength Index (14 RSI): | 64.2 | Buy |
Chaikin Money Flow: | -162874 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (47.46 - 56.8) | Buy |
Bollinger Bands (100): | (45.02 - 53.82) | Buy |
Keros Therapeutics Technical Analysis
Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Keros Therapeutics Stock
Is Keros Therapeutics Stock a Buy?
- Keros Therapeutics share price is 56.92 while KROS 8-day simple moving average is 55.92, which is a Buy signal.
- The stock price of KROS is 56.92 while Keros Therapeutics 20-day SMA is 53.86, which makes it a Buy.
- Keros Therapeutics 50-day simple moving average is 50.03 while KROS share price is 56.92, making it a Buy technically.
- KROS stock price is 56.92 and Keros Therapeutics 200-day simple moving average is 52.70, creating a Buy signal.
KROS Technical Analysis vs Fundamental Analysis
Buy
62
Keros Therapeutics (KROS)
is a Buy
Is Keros Therapeutics a Buy or a Sell?
-
Keros Therapeutics stock is rated a Buy
The current Keros Therapeutics [KROS] share price is $56.92. The Score for KROS is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
Keros Therapeutics Stock Info
Market Cap:
2.14B
Price in USD:
56.92
Share Volume:
283.99K
Keros Therapeutics 52-Week Range
52-Week High:
73.00
52-Week Low:
27.02
Buy
62
Keros Therapeutics (KROS)
is a Buy
Keros Therapeutics Share Price Forecast
-
What is the Keros Therapeutics stock price today?
The Keros Therapeutics stock price is 56.92 USD today. -
Will KROS stock go up or go down?
Keros Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Keros Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Keros Therapeutics is not overvalued.
Is Keros Therapeutics Stock a Buy?
- Keros Therapeutics share price is 56.92 while KROS 8-day exponential moving average is 55.87, which is a Buy signal.
- The stock price of KROS is 56.92 while Keros Therapeutics 20-day EMA is 53.93, which makes it a Buy.
- Keros Therapeutics 50-day exponential moving average is 51.33 while KROS share price is 56.92, making it a Buy technically.
- KROS stock price is 56.92 and Keros Therapeutics 200-day simple moving average is 49.85, creating a Buy signal.
Fundamental Analysis of Keros Therapeutics
Is Keros Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.02 per share, an increase this year of $0.30 per share, and a decrease next year of $0.44 per share.
Technical Analysis of Keros Therapeutics
Should I short Keros Therapeutics stock?
- KROS Moving Average Covergence Divergence (MACD) indicator is 2.17, suggesting Keros Therapeutics is a Buy
- Keros Therapeutics Relative Strength Index (RSI) is 64.2, which suggest Keros Therapeutics is overbought
- The Bollinger Bands (25) for Keros Therapeutics is (47.46 - 56.8), which suggest Keros Therapeutics is a Buy
- The Bollinger Bands (100) for Keros Therapeutics is (45.02 - 53.82), which suggest Keros Therapeutics is a Buy
* Keros Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.